We are live on ! Find out more
MF

Magnetar Financial Portfolio holdings

AUM $9.84B
1-Year Est. Return 190.64%
This Fund
S&P 500
This Quarter Est. Return
+20.34%
1 Year Est. Return
+190.64%
3 Year Est. Return
+293.18%
5 Year Est. Return
+491.79%
10 Year Est. Return
+5,174.28%
AUM
$4.79B
AUM Growth
+$861M
Cap. Flow
+$375M
Cap. Flow %
7.83%
Top 10 Hldgs %
40.45%
Holding
705
New
237
Increased
66
Reduced
135
Closed
181

Sector Composition

Rank Sector Weight
1 Healthcare 22.85%
2 Technology 13.83%
3 Consumer Discretionary 12.4%
4 Industrials 5.52%
5 Financials 5.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGN
1
DELISTED
Allergan plc
AGN
$243M 5.07%
1,271,006
-79,151
-6% -$14.3M
WCG
2
DELISTED
Wellcare Health Plans, Inc.
WCG
$221M 4.62%
670,556
-147,097
-18% -$44.2M
CZR
3
DELISTED
Caesars Entertainment Corporation
CZR
$203M 4.23%
14,906,751
+17,220
+0.1% +$218K
AMTD
4
DELISTED
TD Ameritrade Holding Corp
AMTD
$195M 4.07%
+3,929,094
New +$170M
WBC
5
DELISTED
WABCO HOLDINGS INC.
WBC
$193M 4.04%
1,427,802
-49,886
-3% -$6.73M
TIF
6
DELISTED
Tiffany & Co.
TIF
$188M 3.93%
+1,408,622
New +$166M
WMGI
7
DELISTED
Wright Medical Group Inc
WMGI
$184M 3.83%
+6,020,854
New +$158M
CY
8
DELISTED
Cypress Semiconductor
CY
$178M 3.72%
7,638,793
+13,337
+0.2% +$312K
MLNX
9
DELISTED
Mellanox Technologies, Ltd.
MLNX
$172M 3.59%
1,469,416
-36,687
-2% -$4.17M
MDCO
10
DELISTED
Medicines Co
MDCO
$161M 3.35%
+1,892,832
New +$126M
ACIA
11
DELISTED
Acacia Communications Inc
ACIA
$129M 2.68%
1,895,234
-49,173
-3% -$3.26M
ADSW
12
DELISTED
Advanced Disposal Services Inc
ADSW
$106M 2.22%
3,232,909
-75,910
-2% -$2.49M
BOLD
13
DELISTED
Audentes Therapeutics, Inc
BOLD
$95.4M 1.99%
+1,594,605
New +$59.8M
RARX
14
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$86.3M 1.8%
+1,838,506
New +$81.3M
UBER icon
15
Uber
UBER
$140B
$85.1M 1.78%
2,861,012
-444,666
-13% -$13.2M
S
16
DELISTED
Sprint Corporation
S
$85M 1.77%
16,306,411
-3,183,008
-16% -$18.7M
FIT
17
DELISTED
Fitbit, Inc. Class A common stock
FIT
$80.3M 1.68%
+12,219,993
New +$71.7M
KEM
18
DELISTED
KEMET Corporation
KEM
$77.8M 1.62%
+2,875,899
New +$69.8M
ET icon
19
Energy Transfer Partners
ET
$70.3B
$61.7M 1.29%
4,809,557
+897,483
+23% +$11.1M
TSG
20
DELISTED
The Stars Group Inc.
TSG
$53.9M 1.12%
+2,066,132
New +$46.2M
CCX.U
21
DELISTED
Churchill Capital Corp II
CCX.U
$53.9M 1.12%
5,000,000
INXN
22
DELISTED
Interxion Holding N.V.
INXN
$48.7M 1.02%
+581,215
New +$48.5M
ARQL
23
DELISTED
Arqule Inc
ARQL
$47.6M 0.99%
+2,386,795
New +$27.7M
CBPX
24
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
$46.9M 0.98%
+1,286,176
New +$42.3M
NVST icon
25
Envista
NVST
$4.26B
$35.6M 0.74%
1,202,175
+739,175
+160% +$21M

Similar funds

Magnetar Financial's Q4 2019 Portfolio in Review

As of Q4 2019, Magnetar Financial held 705 positions worth $4.79B, up 22% from $3.93B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Magnetar Financial deployed $375M of net new capital in Q4 2019, opening 237 new positions and adding to 66 existing holdings. Its largest new stake was TD Ameritrade Holding Corp: 3,929,094 shares worth $195M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $44.2M trimmed.

  • Magnetar Financial's largest Q4 2019 buy was TD Ameritrade Holding Corp: 3,929,094 shares worth $195M.
  • Magnetar Financial added most to Envista in Q4 2019, an estimated $21M increase.
  • Magnetar Financial's biggest Q4 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $44.2M.
  • Magnetar Financial fully exited Celgene Corp in Q4 2019, selling an estimated $172M.
  • Magnetar Financial's ten largest holdings make up 40% of its $4.79B portfolio in Q4 2019.
  • Magnetar Financial opened 237 new positions and closed 181 in Q4 2019.
  • Magnetar Financial's portfolio value rose 22% quarter-over-quarter to $4.79B.

Based on Magnetar Financial's 13F filing for Q4 2019, filed 13 Feb 2020.